Advanced Biomed Inc. SEC filings ADVB
Advanced Biomed Inc. has 98 filings in SEC EDGAR's recent list, going back to Nov 30, 2022. Its latest annual report, Form 10-K, was filed on Oct 13, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 15, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Jul 17, 2026 (agreement ended). The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| NT 10-K | Filing | Sep 28, 2026 | Jun 30, 2026 |
| RW | Withdrawal request | Jul 20, 2026 | — |
| NT 10-Q | Notification of late filing | Nov 14, 2025 | Sep 30, 2025 |
| NT 10-K | Notification of late filing | Sep 30, 2025 | Jun 30, 2025 |
| CERT | Filing | Mar 6, 2025 | — |
| 8-A12B | Form 8a-12(b) | Mar 5, 2025 | — |
| SEC STAFF LETTER | Filing | Feb 13, 2025 | — |
| EFFECT | Filing | Feb 11, 2025 | — |
| CORRESP | Letter to the SEC | Feb 10, 2025 | — |
| CORRESP | Letter to the SEC | Feb 10, 2025 | — |
| SEC STAFF LETTER | Filing | Jan 28, 2025 | — |
| CORRESP | Letter to the SEC | Jan 27, 2025 | — |
| UPLOAD | Letter from the SEC | Jan 22, 2025 | — |
| CORRESP | Letter to the SEC | Jan 7, 2025 | — |
| UPLOAD | Letter from the SEC | Nov 21, 2024 | — |
| CORRESP | Letter to the SEC | Jan 19, 2024 | — |
| UPLOAD | Letter from the SEC | Jan 17, 2024 | — |
| CORRESP | Letter to the SEC | Jan 9, 2024 | — |
| UPLOAD | Letter from the SEC | Jan 5, 2024 | — |
| CORRESP | Letter to the SEC | Dec 22, 2023 | — |
| UPLOAD | Letter from the SEC | Dec 18, 2023 | — |
| CORRESP | Letter to the SEC | Dec 13, 2023 | — |
| UPLOAD | Letter from the SEC | Dec 12, 2023 | — |
| CORRESP | Letter to the SEC | Dec 5, 2023 | — |
| UPLOAD | Letter from the SEC | Nov 30, 2023 | — |
| CORRESP | Letter to the SEC | Nov 20, 2023 | — |
| UPLOAD | Letter from the SEC | Nov 6, 2023 | — |
| CORRESP | Letter to the SEC | Oct 27, 2023 | — |
| UPLOAD | Letter from the SEC | Sep 8, 2023 | — |
| CORRESP | Letter to the SEC | Aug 28, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 25, 2023 | — |
| CORRESP | Letter to the SEC | Aug 11, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 1, 2023 | — |
| CORRESP | Letter to the SEC | Jul 18, 2023 | — |
| UPLOAD | Letter from the SEC | Jul 5, 2023 | — |
| CORRESP | Letter to the SEC | Jun 20, 2023 | — |
| UPLOAD | Letter from the SEC | Jun 7, 2023 | — |
| CORRESP | Letter to the SEC | May 19, 2023 | — |
| UPLOAD | Letter from the SEC | Mar 17, 2023 | — |
| DRS/A | Filing | Mar 6, 2023 | — |
| DRSLTR | Filing | Mar 3, 2023 | — |
| UPLOAD | Letter from the SEC | Dec 27, 2022 | — |
| DRS | Filing | Nov 30, 2022 | — |
Showing 43 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Medical Laboratories (SIC 8071)
- Listed as
- ADVB (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- NV
- Headquarters
- Reno, NV
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1941029
Other Services-Medical Laboratories companies
- Natera, Inc. NTRA
- Labcorp Holdings Inc. LH
- Quest Diagnostics Inc DGX
- Guardant Health, Inc. GH
- Caris Life Sciences, Inc. CAI
- GRAIL, Inc. GRAL
- RadNet, Inc. RDNT
- BillionToOne, Inc. BLLN
Source: SEC EDGAR filings. This is company-reported data, not investment advice.